News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

New VP Sales, Michael Rossi, Appointed At Jubilant Draximage Inc.

4/10/2014 6:31:48 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MONTREAL, April 9, 2014 /PRNewswire/ - Jubilant DraxImage Inc., a Jubilant Life Sciences Company, is pleased to announce the appointment of Mr. Michael Rossi as Vice President, Sales and Business Operations, Jubilant DraxImage Inc., with effect from the 21stApril 2014.

Mr. Rossi has worked for GE Healthcare, Life Sciences since 2002, and currently holds the position of General Manager, Global SPECT Business. During his tenure with GE, he has led several commercial organizations with responsibility for generating sales of hundreds of millions of dollars, and managing many sales representatives, managers and regional directors focused within radiopharmaceuticals and contrast media. Mr. Rossi joined GE as a Nuclear Pharmacy Manager in 2002, and prior to that he worked for Tyco Healthcare/Mallinckrodt. Mr. Rossi holds a Bachelor of Science degree in Pharmacy from The University of the Sciences Philadelphia College of Pharmacy and is an Authorized Nuclear Pharmacist from Butler University.

Martyn Coombs, President of Jubilant DraxImage Inc, stated "We are very pleased to welcome Mike to our team. He is a significant addition with an impressive track record, and we intend that Mike will play a key leadership role in helping us transform ourselves into one of the industry leaders."

About Jubilant DraxImage Inc.

Jubilant DraxImage Inc., a subsidiary of Jubilant Life Sciences, develops, manufactures and commercializes radiopharmaceuticals used for the diagnosis and treatment of disease. The company is dedicated to nuclear medicine and serves customers and through them patients, globally, with high quality and reliable products and services. The company is the market leader in North America for I-131 products (diagnosis and treatment of thyroid disorder and cancer), MAA (lung perfusion imaging), DTPA (renal imaging) and MDP (bone imaging), and also markets other products such as Sestamibi and Gluceptate. The company has a strong development pipeline of new products, notably a Rubidium-82 Generator (PET Cardiology).

SOURCE Jubilant DraxImage Inc.

Help employers find you! Check out all the jobs and post your resume.

Read at

comments powered by Disqus